PYXIS ONCOLOGY, INC. Share | Buy US Stock from India on Kuvera

Q: Can I buy PYXIS ONCOLOGY, INC. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell PYXIS ONCOLOGY, INC. stocks after a simple registration process. </div>

Q: How to buy PYXIS ONCOLOGY, INC. shares in India?

<div> To buy PYXIS ONCOLOGY, INC. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for PYXIS ONCOLOGY, INC. and you are done!</div> </div>

Q: What is the share price of PYXIS ONCOLOGY, INC.?

<div>The share price of PYXIS ONCOLOGY, INC. is USD 2.68 as on 3 Aug.</div>

Q: What is the Market Capitalization of PYXIS ONCOLOGY, INC.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of PYXIS ONCOLOGY, INC. is USD 87.95M as on 3 Aug.</div>

Q: What is the PE ratio of PYXIS ONCOLOGY, INC.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of PYXIS ONCOLOGY, INC. is N/A as on 3 Aug. </div>

Q: Is PYXIS ONCOLOGY, INC. a good stock to buy?

<div>Kuvera provides relevant fundamental details of PYXIS ONCOLOGY, INC. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does PYXIS ONCOLOGY, INC. operate?

<div> PYXIS ONCOLOGY, INC. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$2.68

+0.03

(7:59 pm IST)

Loading Chart

Previous close

$2.68

Open

$2.68

52W high

$19

1.13%

Shares O/S

32.82M

Market cap

87.95M

Insights

No insights found for this stock

Compare with other stock

About PYXIS ONCOLOGY, INC.

Pyxis Oncology, Inc. is a preclinical oncology company that is focused on developing a range of therapeutics to treat cancers. The Company has developed a portfolio of antibody drug conjugate (ADC), immuno-oncology (IO), product candidates, and monoclonal antibody (mAb), preclinical discovery programs that are developing as monotherapies and in combination with other therapies.

Its pipeline includes PYX-106, PYX-102, PYX-201, PYX-202 and PYX-203. Its PYX-106 is an investigational, fully human IgG1 isotype Siglec-15 targeting antibody that is designed to block Siglec-15-mediated suppression of T-cell proliferation and function. PYX-102 is an investigational immune-therapeutic consisting of a ligand-blocking antibody which rescues KLRG1-mediated suppression of human CD8+ T cells. PYX-201 is an investigational ADC consisting of an immunoglobulin G1 (IgG1), anti-fibronectin Extradomain-B (EDB), mAb site-specifically conjugated to auristatin via a cathepsin B-cleavable linker. .

FAQs

Can I buy PYXIS ONCOLOGY, INC. shares in India?

How to buy PYXIS ONCOLOGY, INC. shares in India?

What is the share price of PYXIS ONCOLOGY, INC.?

What is the Market Capitalization of PYXIS ONCOLOGY, INC.?

What is the PE ratio of PYXIS ONCOLOGY, INC.?

Is PYXIS ONCOLOGY, INC. a good stock to buy?

In which sector / industry does PYXIS ONCOLOGY, INC. operate?